| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer | Chief Innovation Officer | See Remarks
1 company
Scheibler Lukas is a Chief Research Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $3.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Research Officer | Sale+OE | 10,000 | $60.00 | $600,000.00 | -12.8% | +0.6% | -44.9% | |
| Sep 6, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Research Officer | Sell | 1,756 | $43.01 | $75,525.56 | -2.5% | +51.6% | -8.1% | |
| May 27, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Innovation Officer | Sell | 10,000 | $43.00 | $430,000.00 | -19.9% | +39.2% | +104.1% | |
| Apr 5, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Innovation Officer | Sale+OE | 609 | $60.09 | $36,592.98 | -1.2% | -18.9% | +30.6% | |
| Apr 4, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Innovation Officer | Sale+OE | 3,504 | $56.96 | $199,589.13 | -2.1% | -17.7% | +33.8% | |
| Apr 1, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Innovation Officer | Sale+OE | 11,496 | $55.05 | $632,854.80 | -18.0% | -17.8% | +20.0% | |
| Feb 11, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Innovation Officer | Sell | 1,666 | $46.80 | $77,968.80 | -3.1% | -20.7% | +10.8% | |
| Feb 10, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Innovation Officer | Sale+OE | 10,000 | $50.00 | $500,000.00 | -15.8% | -25.6% | +8.7% | |
| Feb 8, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Innovation Officer | Sale+OE | 10,000 | $45.00 | $450,000.00 | -15.7% | -18.9% | +15.4% | |
| Jan 31, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Innovation Officer | Sell | 1,233 | $38.47 | $47,433.51 | -2.2% | +11.6% | +30.9% |